Quadruple ICS reduces severe asthma exacerbations

A self managed four-fold increase in the dose of inhaled corticosteroids reduces severe asthma exacerbations, a late breaking trial at ERS Congress reports. According to the lead author Professor Tim Harrison, a respiratory physician from the University of Nottingham in the UK, the findings are likely to find their way into asthma guidelines in the ...